← Back to directory

Carol Brayne

Researcher Next ID · RN-027806

Researcher · Medicine

University of Cambridge

Cambridge, United Kingdom

Not currently recruitingFunding unknown
Works count
1,202
Citation count
219,157
H-index
160
i10-index
745

Research interests

Medicine
Social Sciences
Economics, Econometrics and Finance
Dementia and Cognitive Impairment Research
Alzheimer's disease research and treatments
Health disparities and outcomes
Frailty in Older Adults
Health Systems, Economic Evaluations, Quality of Life

Publications

  • Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission

    The Lancet · 2024 · https://doi.org/10.1016/s0140-6736(24)01296-0

  • Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

    The Lancet Public Health · 2022 · https://doi.org/10.1016/s2468-2667(21)00249-8

  • Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

    The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)30367-6

  • Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report

    Brain · 2019 · https://doi.org/10.1093/brain/awz099

  • Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

    The Lancet Neurology · 2019 · https://doi.org/10.1016/s1474-4422(18)30499-x

  • Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

    The Lancet Neurology · 2018 · 10.1016/s1474-4422(18)30403-4

  • Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

    The Lancet Neurology · 2018 · 10.1016/s1474-4422(18)30295-3

  • The changing prevalence and incidence of dementia over time — current evidence

    Nature Reviews Neurology · 2017 · 10.1038/nrneurol.2017.63

  • Defeating Alzheimer's disease and other dementias: a priority for European science and society

    The Lancet Neurology · 2016 · 10.1016/s1474-4422(16)00062-4

  • Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition

    The Lancet · 2015 · 10.1016/s0140-6736(15)61340-x

  • Mild cognitive impairment: a concept in evolution

    Journal of Internal Medicine · 2014 · 10.1111/joim.12190

  • Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease

    PLoS ONE · 2014 · 10.1371/journal.pone.0094661

  • Potential for primary prevention of Alzheimer's disease: an analysis of population-based data

    The Lancet Neurology · 2014 · 10.1016/s1474-4422(14)70136-x

  • Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Nature Genetics · 2013 · 10.1038/ng.2802

  • Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

    The Lancet Neurology · 2013 · https://doi.org/10.1016/s1474-4422(13)70124-8

  • A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II

    The Lancet · 2013 · 10.1016/s0140-6736(13)61570-6

  • Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

    The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)61729-2

  • Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

    The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)61689-4

  • Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

    Nature Genetics · 2011 · 10.1038/ng.803

  • Epidemiology of Alzheimer disease

    Nature Reviews Neurology · 2011 · 10.1038/nrneurol.2011.2

  • Alzheimer's disease

    The Lancet · 2011 · 10.1016/s0140-6736(10)61349-9

  • Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease

    PLoS ONE · 2010 · 10.1371/journal.pone.0013950

  • Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

    Nature Genetics · 2009 · 10.1038/ng.440

  • Global prevalence of dementia: a Delphi consensus study

    The Lancet · 2005 · 10.1016/s0140-6736(05)67889-0

  • A systematic review of prevalence studies of dementia in Parkinson's disease

    Movement Disorders · 2005 · 10.1002/mds.20527

  • Risk of dementia in diabetes mellitus: a systematic review

    The Lancet Neurology · 2005 · 10.1016/s1474-4422(05)70284-2

  • The prevalence of frontotemporal dementia

    Neurology · 2002 · 10.1212/wnl.58.11.1615

Current projects

    No projects listed.